Henry Ford Health System in Detroit has selected Dr. Steven N. Kalkanis to be CEO of Henry Ford Medical Group following a national search. He succeeded Dr. William A. Conway, who stepped down after more than four decades with the health system. Kalkanis’ position was effective Jan. 1.
Kalkanis will lead and direct the more than 1,900-member group of physicians and researchers, who are responsible for all aspects of clinical performance across 40 specialties. Along with his role, he serves as senior vice president and chief academic officer. His tasks include advancing the health system’s academic mission and developing and advancing all research and medical education programs.
“We are proud to welcome Dr. Steven Kalkanis to this expanded role,” says Wright L. Lassiter III, president and CEO of the health system. “Not only is Steve an accomplished and recognized neurosurgeon, he is a transformational leader who can build on the strong history and tradition of the Henry Ford Medical Group.”
Kalkanis joined Henry Ford in 2004 and was most recently chair of health system’s department of neurosurgery, which is ranked among the nation’s best by U.S. News and World Report. He was also the medical director of the Henry Ford Cancer Institute. He is internationally recognized as a brain tumor expert and serves as president of the Congress of Neurological Surgeons. In 2018, he was also named a director of the American Board of Neurological Surgery, the accrediting and credentialing body for neurosurgeons practicing in the U.S.
The metro Detroit native is a graduate of Harvard University and Harvard Medical School. He also completed neurosurgical training at Massachusetts General Hospital in Boston.